CAMBRIDGE, Mass. (November 7, 2016) – Platelet BioGenesis, a biotech startup developing a method for producing life-saving platelets without the need for human donations, is excited to announce the launch of its newly redesigned website, www.plateletbiogenesis.com!
The new site has undergone a complete makeover from top to bottom and features a cleaner and more attractive design, improved functionality and additional Company information. The improved site also features a brand new recruitment section in search of the best and brightest for their endeavors.
“Our Big Dig is finally done! PBG version 2.0 should offer a lot more functionality and make it easier for us to communicate our progress with the public. We’re excited to share the fruits of that labor.” says Dr. Jonathan Thon, Co-Founder of Platelet BioGenesis.
Platelet BioGenesis’ new website will be updated regularly with Company news, milestones, events and investor information. Visitors are encouraged to explore the new website and sign up for direct emails to keep tabs on this important venture at www.plateletbiogenesis.com/contact/.
About Platelet BioGenesis
(www.plateletbiogenesis.com; twitter @plateletbiogen)
Platelet BioGenesis is a pre-clinical stage biotech company that was spun out of Harvard in 2014 to produce donor-independent human platelets from pluripotent stem cells Platelet BioGenesis has developed and patented a microfluidic bioreactor, and shown that functional platelets can be generated from human stem cell cultures at scale. The company was selected to participate in MassCONNECT (run by MassBio), was a 2014 MassChallenge Finalist, a 2016 BioSciKin business competition winner, and has received support from the Massachusetts Life Sciences Center, and the NIH.
Platelet BioGenesis Whitney Berry | (720) 509.9448 email@example.com